Rigel Pharmaceuticals, Inc. (RIGL) Reports Q3 Loss of $0.25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 50.55 +0.64 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.91 | 52 Week High | $4.38 | |||
| Open | $50.09 | 52 Week Low | $1.88 | |||
| Day High | $50.70 | P/E | N/A | |||
| Day Low | $49.54 | EPS | $-1.12 | |||
| Volume | 133,103 | |||||
